BBBYQ stock looks toxic as the corporate vultures circle around Bed Bath & Beyond and consider buying its assets at fire-sale prices. More
Articles
The ‘Shiny Ball Syndrome’ Trap In AI Investing Is Real. Here’s How to Avoid It.
The company we’re about to discuss in today’s Market 360 is not one of my official recommendations, but it does rate well in Portfolio Grader (it currently holds a B-rating) and is a good play on the AI space. More
3 Gene Testing Stocks to Buy Before They Take Off
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry. More
3 Analysts Betting Big on Microsoft (MSFT) Stock at Record Highs
MSFT stock is the talk of Wall Street since the tech giant managed to surpass its 2021 all-time high share price. More